(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) rose 8.49% to $33.24 at 11:24 EST on Wednesday, following the last session’s upward trend. NASDAQ is jumping 2.2% to $12,769.24, after three sequential sessions in a row of losses. This seems, as yet, an all-around positive trend trading session today.

Castle Biosciences’s last close was $30.64, 61.01% under its 52-week high of $78.58.


Today’s last reported volume for Castle Biosciences is 57095 which is 82.13% below its average volume of 319564.

The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.


Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 1.48%, 0.53%, and 4.98%, respectively.

Castle Biosciences’s highest amplitude of average volatility was 3.34% (last week), 3.74% (last month), and 4.98% (last quarter), respectively.

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $33.24 at 11:25 EST, way under its 52-week high of $78.58 and way higher than its 52-week low of $15.58.

Castle Biosciences’s Moving Average

Castle Biosciences’s worth is way higher than its 50-day moving average of $22.43 and below its 200-day moving average of $36.79.

More news about Castle Biosciences (CSTL).


Please enter your comment!
Please enter your name here